SELLAS Life Sciences Group, Inc. Common Stock Earnings Dividend
Earnings Summary
Revenue | $0Mn |
Net Profits | $-9.61Mn |
Net Profit Margins | -Inf% |
SELLAS Life Sciences Group, Inc. Common Stock’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2026. On a quarterly growth basis, SELLAS Life Sciences Group, Inc. Common Stock has generated NaN% jump in its revenue since last 3-months.
SELLAS Life Sciences Group, Inc. Common Stock’s net profit fell -45.51% since last year same period to $-9.61Mn in the Q2 2026. On a quarterly growth basis, SELLAS Life Sciences Group, Inc. Common Stock has generated -14.25% fall in its net profits since last 3-months.
SELLAS Life Sciences Group, Inc. Common Stock’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2026. On a quarterly growth basis, SELLAS Life Sciences Group, Inc. Common Stock has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.05 |
EPS Estimate Current Year | -0.05 |
SELLAS Life Sciences Group, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at -0.05 - a -25% fall from last quarter’s estimates.
SELLAS Life Sciences Group, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at -0.05.
Key Ratios
Earning Per Share (EPS) | -0.05 |
SELLAS Life Sciences Group, Inc. Common Stock’s earning per share (EPS) jumped 28.57% since last year same period to -0.05 in the Q2 2026. This indicates that the SELLAS Life Sciences Group, Inc. Common Stock has generated 28.57% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-08-11 | -0.04 | -0.05 | -25% |
2026-05-12 | -0.07 | -0.05 | 30.43% |
